---
title: "中生北控生物科技股份有限公司 (08247.HK)"
type: "quote"
locale: "en"
url: "https://longbridge.com/en/quote/08247.HK.md"
symbol: "08247.HK"
name: "中生北控生物科技股份有限公司"
industry: "生物技術"
---

# 中生北控生物科技股份有限公司 (08247.HK)

| Item | Detail |
|------|--------|
| Industry | 生物技術 |
| Location | 港股市場 |
| Website | [www.sinobio.com.cn](https://www.sinobio.com.cn) |

## Company Profile

中生北控生物科技股份有限公司是一家主要從事體外診斷試劑產品研發、製造、銷售及分銷業務的中國公司。該公司產品包括單診斷試劑產品及雙診斷試劑產品。該公司產品類型包括肝功類、腎功類、血脂類、心肌類、糖代謝類、無機離子類、胰腺疾病類及特種蛋白類。該公司產品銷往醫院及醫療機構。

## Financial Score

> *Longbridge Financial Score™ — Proprietary multi-factor rating model by [Longbridge](https://longbridge.com). This score is independently calculated by Longbridge and is not affiliated with any third-party rating agency.*
> Updated: 2026-02-14T04:30:10.000Z

**Overall: D (0.73)**

**Industry**: Biotechnology

| Metric | Value |
|--------|-------|
| Industry Ranking | 50 / 53 |
| Industry Median | C |
| Industry Average | C |

- **Style**: Value - Stocks where the company's main business is in a mature stage.
- **Scale**: Small - The company's operation has a high degree of growth and volatility, making it easy to achieve high investment returns.

### Score Analysis

**Style Score**: 

#### Growth Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Revenue YoY | -20.57% |  |
| Net Profit YoY | -144.23% |  |

#### Value Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| P/B Ratio | 4.46 |  |
| Dividend Ratio | 0.00% |  |


**Size Score**: 

#### Market Cap Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Market Cap | 732.16M |  |

#### Revenue Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Revenue | 244.02M |  |


**Multi Score**: D

#### Profit Score: D

| Indicator | Value | Rating |
|-----------|-------|--------|
| ROE | -27.27% | E |
| Profit Margin | -21.03% | D |
| Gross Margin | 39.01% | B |

#### Growth Score: E

| Indicator | Value | Rating |
|-----------|-------|--------|
| Revenue YoY | -20.57% | E |
| Net Profit YoY | -144.23% | E |
| Total Assets YoY | -17.36% | E |
| Net Assets YoY | -25.85% | E |

#### Cash Score: E

| Indicator | Value | Rating |
|-----------|-------|--------|
| Cash Flow Margin | -475.54% | E |
| OCF YoY | -20.57% | E |

#### Operating Score: C

| Indicator | Value | Rating |
|-----------|-------|--------|
| Turnover | 0.46 | C |

#### Debt Score: D

| Indicator | Value | Rating |
|-----------|-------|--------|
| Gearing Ratio | 64.36% | D |


```chart-data:radar
{
  "title": "Longbridge Financial Score - 中生北控生物科技股份有限公司",
  "chart_type": "radar",
  "dimensions": [
    {
      "name": "Profit",
      "grade": "D",
      "indicators": [
        {
          "name": "ROE",
          "value": "-27.27%",
          "rating": "E"
        },
        {
          "name": "Profit Margin",
          "value": "-21.03%",
          "rating": "D"
        },
        {
          "name": "Gross Margin",
          "value": "39.01%",
          "rating": "B"
        }
      ]
    },
    {
      "name": "Growth",
      "grade": "E",
      "indicators": [
        {
          "name": "Revenue YoY",
          "value": "-20.57%",
          "rating": "E"
        },
        {
          "name": "Net Profit YoY",
          "value": "-144.23%",
          "rating": "E"
        },
        {
          "name": "Total Assets YoY",
          "value": "-17.36%",
          "rating": "E"
        },
        {
          "name": "Net Assets YoY",
          "value": "-25.85%",
          "rating": "E"
        }
      ]
    },
    {
      "name": "Cash",
      "grade": "E",
      "indicators": [
        {
          "name": "Cash Flow Margin",
          "value": "-475.54%",
          "rating": "E"
        },
        {
          "name": "OCF YoY",
          "value": "-20.57%",
          "rating": "E"
        }
      ]
    },
    {
      "name": "Operating",
      "grade": "C",
      "indicators": [
        {
          "name": "Turnover",
          "value": "0.46",
          "rating": "C"
        }
      ]
    },
    {
      "name": "Security",
      "grade": "D",
      "indicators": [
        {
          "name": "Gearing Ratio",
          "value": "64.36%",
          "rating": "D"
        }
      ]
    }
  ]
}
```

### Peer Comparison

| Rank | Name | Profit | Growth | Operation | Security | Cash | Rating |
|------|------|--------|--------|-----------|----------|------|--------|
| 01 | 百濟神州 (HK.6160) | C | A | B | C | A | B |
| 02 | 信達生物 (HK.1801) | B | A | C | B | A | B |
| 03 | 三生制藥 (HK.1530) | A | B | C | A | C | B |
| 04 | 百奧賽圖-B (HK.2315) | A | A | C | D | B | B |
| 05 | 和鉑醫藥-B (HK.2142) | A | A | C | B | B | B |

## Valuation Analysis

| Metric | Current | Industry Ranking | High | Median | Low |
|--------|---------|-----------------|------|--------|-----|
| PE (TTM) | -14.11 | 39/70 | - | - | - |
| PB | 4.46 | 28/70 | 1.82 | 0.70 | 0.46 |
| PS (TTM) | 2.97 | 9/70 | 1.21 | 0.46 | 0.30 |
| Dividend Yield | 0.00% | - | - | - | - |

## References

- [Company Overview](https://longbridge.com/en/quote/08247.HK/overview.md) - Shareholders, executives, business segments
- [Financials](https://longbridge.com/en/quote/08247.HK/norm.md) - Income statement, balance sheet, cash flow, distribution plan
- [Topics & Discussions](https://longbridge.com/en/quote/08247.HK/topics.md) - Community topics and discussions

---

> **Disclaimer**: This article is for reference only and does not constitute any investment advice.